A. Tanuri

Lessons from a multilaboratorial task force for diagnosis of a fatal toxoplasmosis outbreak in captive primates in Brazil

The paper describes an outbreak of toxoplasmosis in captive primates during the COVID-19 pandemic, identifying Toxoplasma gondii as the causative agent through a collaborative, interdisciplinary investigation.

Polycomb Repressive Complex 1 subunit Cbx4 positively regulates effector responses in CD8 T cells

This study shows that Cbx4 promotes effector CD8 T cell differentiation through SUMOylation and chromodomain mechanisms, impacting memory cell formation during viral infection.

Immunogenicity of SARS-CoV-2 trimetric spike protein associated to Poly(I:C) plus Alum

This study evaluates a vaccine strategy using Alum and Poly(I:C) adjuvants with SARS-CoV-2 spike protein, showing enhanced antibody and T-cell responses and reduced lung inflammation.

Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy

This study produces potent equine antibodies against SARS-CoV-2 spike protein with high neutralizing titers, supporting a clinical trial for passive immunization therapy.

Ultrastructural analysis of SARS-CoV-2 interactions with the host cell via high resolution scanning electron microscopy

This paper uses high resolution scanning electron microscopy to examine SARS-CoV-2 interactions with Vero cells at 2 and 48 hours post-infection, revealing new structural insights into viral processing and transmission.

Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo

This study shows that sofosbuvir inhibits Yellow fever virus replication in vitro and protects mice from infection, suggesting it as a potential therapeutic option.

Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequela

This study shows sofosbuvir reduces ZIKV levels and improves survival and long-term memory in infected mice.